Your browser doesn't support javascript.
loading
Feasibility of intravitreal injections and ophthalmic safety assessment in marmoset (Callithrix jacchus) monkeys.
Korbmacher, Birgit; Atorf, Jenny; Fridrichs-Gromoll, Stephanie; Hill, Marilyn; Korte, Sven; Kremers, Jan; Mansfield, Keith; Mecklenburg, Lars; Pilling, Andrew; Wiederhold, Andreas.
Afiliação
  • Korbmacher B; Covance Preclinical Services GmbH, Kesselfeld 29, 48163 Münster, Germany.
  • Atorf J; Department of Ophthalmology, University Hospital Erlangen, Maximiliansplatz 2, 91054 Erlangen, Germany.
  • Fridrichs-Gromoll S; Covance Preclinical Services GmbH, Kesselfeld 29, 48163 Münster, Germany.
  • Hill M; Novartis Pharma AG, Basel, Klybeckstraße, 4002 Basel, Switzerland.
  • Korte S; Covance Preclinical Services GmbH, Kesselfeld 29, 48163 Münster, Germany.
  • Kremers J; Department of Ophthalmology, University Hospital Erlangen, Maximiliansplatz 2, 91054 Erlangen, Germany.
  • Mansfield K; Novartis Pharma AG, Basel, Klybeckstraße, 4002 Basel, Switzerland.
  • Mecklenburg L; Covance Preclinical Services GmbH, Kesselfeld 29, 48163 Münster, Germany.
  • Pilling A; Novartis Pharma AG, Basel, Klybeckstraße, 4002 Basel, Switzerland.
  • Wiederhold A; Covance Preclinical Services GmbH, Kesselfeld 29, 48163 Münster, Germany.
Primate Biol ; 4(1): 93-100, 2017.
Article em En | MEDLINE | ID: mdl-32110696

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2017 Tipo de documento: Article